Post-translational modifications of NLRP3: to prime or not to prime?

The NLRP3 inflammasome plays a central role in host defense against microbial infections but also contributes to inflammatory diseases. Functioning of NLRP3 strictly relies on two signals: a 'priming signal' that licenses NLRP3 activity and an 'activation signal' that triggers inflammasome assembly and downstream caspase-1 activation. The priming signal involves transcriptional upregulation of NLRP3 and diverse post-translational modifications that regulate its stability, subcellular localization, and protein-protein interactions. This multilayered regulation prevents untimely inflammasome activation while enabling its rapid assembly when both priming and activation signals are present. Here, we focus on the complexity of the priming signal and critically analyze and discuss how diverse post-translational modifications cooperate to prime NLRP3, controlling its activity in health and disease.

• Publication year

  2025

• Venue

  Trends in immunology

• Publication date

  2025-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.it.2025.10.008PMID 41219086PMCID PMC13034193
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clustering of NLRP3 induced by membrane or protein scaffolds promotes inflammasome assembly

  2025cited by this paper
• The expanding role of the NLRP3 inflammasome from periodic fevers to therapeutic targets

  2025cited by this paper
• Mechanisms of NLRP3 activation and inhibition elucidated by functional analysis of disease-associated variants

  2025cited by this paper
• NEK7 phosphorylation amplifies NLRP3 inflammasome activation downstream of potassium efflux and gasdermin D.

  2025cited by this paper
• Greasing the wheels of inflammasome formation: regulation of NLRP3 function by S-linked fatty acids

  2025cited by this paper
• Signal-induced NLRP3 phase separation initiates inflammasome activation

  2025cited by this paper
• Insights into palmitoylation-mediated regulation of inflammasomes.

  2025cited by this paper
• The NLR family of innate immune and cell death sensors.

  2024cited by this paper
• Functional diversity of NLRP3 gain-of-function mutants associated with CAPS autoinflammation

  2024cited by this paper
• Serine synthesis sustains macrophage IL-1β production via NAD+-dependent protein acetylation.

  2024cited by this paper
• Cell death.

  2024cited by this paper
• S-acylation of NLRP3 provides a nigericin sensitive gating mechanism that controls access to the Golgi

  2024cited by this paper
• Emerging roles of palmitoylation in pyroptosis.

  2024cited by this paper
• Gasdermins as evolutionarily conserved executors of inflammation and cell death

  2024cited by this paper
• Consecutive palmitoylation and phosphorylation orchestrates NLRP3 membrane trafficking and inflammasome activation.

  2024cited by this paper
• FDA-approved disulfiram inhibits the NLRP3 inflammasome by regulating NLRP3 palmitoylation

  2024cited by this paper
• Post-translational control of NLRP3 inflammasome signaling

  2024cited by this paper
• Biphasic JNK signaling reveals distinct MAP3K complexes licensing inflammasome formation and pyroptosis

  2023cited by this paper
• The discovery of NLRP3 and its function in cryopyrin-associated periodic syndromes and innate immunity

  2023cited by this paper
• Acetylation is required for full activation of the NLRP3 inflammasome

  2023cited by this paper
• Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets

  2023cited by this paper
• NLRP3 Cys126 palmitoylation by ZDHHC7 promotes inflammasome activation

  2023cited by this paper
• Fatty acid synthesis promotes inflammasome activation through NLRP3 palmitoylation

  2023cited by this paper
• BRCC3-Mediated NLRP3 Deubiquitylation Promotes Inflammasome Activation and Atherosclerosis in Tet2 Clonal Hematopoiesis

  2023cited by this paper
• Posttranslational ISGylation of NLRP3 by HERC enzymes facilitates inflammasome activation in models of inflammation

  2023cited by this paper
• Non-decameric NLRP3 forms an MTOC-independent inflammasome

  2023cited by this paper
• A 360° view of the inflammasome: Mechanisms of activation, cell death, and diseases.

  2023cited by this paper
• Structural basis of NINJ1-mediated plasma membrane rupture in cell death

  2023cited by this paper
• Disruptions in endocytic traffic contribute to the activation of the NLRP3 inflammasome

  2023cited by this paper
• Distinct changes in endosomal composition promote NLRP3 inflammasome activation

  2022cited by this paper
• IKKβ primes inflammasome formation by recruiting NLRP3 to the trans-Golgi network.

  2022cited by this paper
• TRIM50 promotes NLRP3 inflammasome activation by directly inducing NLRP3 oligomerization

  2022cited by this paper
• How location and cellular signaling combine to activate the NLRP3 inflammasome

  2022cited by this paper
• NLRP3 leucine-rich repeats control induced and spontaneous inflammasome activation in cryopyrin-associated periodic syndrome.

  2022cited by this paper
• Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels to activate NLRP3 inflammasome and interferon signaling.

  2022cited by this paper
• Structure of the NLRP3 decamer bound to the cytokine release inhibitor CRID3

  2022cited by this paper
• Cryo-EM structures of the active NLRP3 inflammasome disc

  2022cited by this paper
• Structural Mechanisms of NLRP3 Inflammasome Assembly and Activation.

  2022cited by this paper
• TRIM28 SUMOylates and stabilizes NLRP3 to facilitate inflammasome activation

  2021cited by this paper
• Escherichia coli RhoGTPase-activating toxin CNF1 mediates NLRP3 inflammasome activation via p21 activated kinases-1/2 during bacteremia in mice

  2021cited by this paper
• Genetic targeting of Card19 is linked to disrupted NINJ1 expression, impaired cell lysis, and increased susceptibility to Yersinia infection

  2021cited by this paper
• YAP promotes the activation of NLRP3 inflammasome via blocking K27-linked polyubiquitination of NLRP3

  2021cited by this paper
• NLRP3 cages revealed by full-length mouse NLRP3 structure control pathway activation.

  2021cited by this paper
• NLRP3 phosphorylation in its LRR domain critically regulates inflammasome assembly

  2021cited by this paper
• Sensing low intracellular potassium by NLRP3 results in a stable open structure that promotes inflammasome activation

  2021cited by this paper
• TBK1 and IKKε act like an OFF switch to limit NLRP3 inflammasome pathway activation

  2021cited by this paper
• Priming of NLRP3 inflammasome activation by Msn kinase MINK1 in macrophages

  2021cited by this paper
• Ubc13 Promotes K63-Linked Polyubiquitination of NLRP3 to Activate Inflammasome

  2021cited by this paper
• Itaconate confers tolerance to late NLRP3 inflammasome activation

  2021cited by this paper
• ABRO1 stabilizes the deubiquitinase BRCC3 through inhibiting its degradation mediated by the E3 ubiquitin ligase WWP2

  2020cited by this paper
• Bruton tyrosine kinase deficiency augments NLRP3 inflammasome activation and causes IL-1β-mediated colitis.

  2020cited by this paper
• An Acetylation Switch of the NLRP3 Inflammasome Regulates Aging-Associated Chronic Inflammation and Insulin Resistance.

  2020cited by this paper
• The Immunomodulatory Metabolite Itaconate Modifies NLRP3 and Inhibits Inflammasome Activation

  2020cited by this paper
• AKT Regulates NLRP3 Inflammasome Activation by Phosphorylating NLRP3 Serine 5

  2020cited by this paper
• HDAC6 mediates an aggresome-like mechanism for NLRP3 and pyrin inflammasome activation

  2020cited by this paper
• NINJ1 mediates plasma membrane rupture during lytic cell death

  2020cited by this paper
• Alternative splicing regulates stochastic NLRP3 activity

  2019cited by this paper
• Structural mechanism for NEK7-licensed NLRP3 inflammasome activation

  2019cited by this paper
• ABRO1 promotes NLRP3 inflammasome activation through regulation of NLRP3 deubiquitination

  2019cited by this paper
• BTK operates a phospho-tyrosine switch to regulate NLRP3 inflammasome activity

  2019cited by this paper
• The E3 ubiquitin ligase Pellino2 mediates priming of the NLRP3 inflammasome

  2018cited by this paper
• Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice

  2018cited by this paper
• PtdIns4P on Dispersed Trans-Golgi Network Mediates NLRP3 Inflammasome Activation

  2018cited by this paper
• SUMO-mediated regulation of NLRP3 modulates inflammasome activity

  2018cited by this paper
• New mitochondrial DNA synthesis enables NLRP3 inflammasome activation

  2018cited by this paper
• New workflow for classification of genetic variants’ pathogenicity applied to hereditary recurrent fevers by the International Study Group for Systemic Autoinflammatory Diseases (INSAID)

  2018cited by this paper
• NLRP3 inflammasome assembly is regulated by phosphorylation of the pyrin domain

  2017cited by this paper
• Protein kinase D at the Golgi controls NLRP3 inflammasome activation

  2017cited by this paper
• Inflammation, metaflammation and immunometabolic disorders

  2017cited by this paper
• NLRP3 Phosphorylation Is an Essential Priming Event for Inflammasome Activation.

  2017cited by this paper
• Nek7 is an essential mediator of NLRP3 activation downstream of potassium efflux

  2016cited by this paper
• NLRP3 inflammasome inhibition is disrupted in a group of auto-inflammatory disease CAPS mutations

  2016cited by this paper
• Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores

  2016cited by this paper
• The E3 ubiquitin ligase TRIM31 attenuates NLRP3 inflammasome activation by promoting proteasomal degradation of NLRP3

  2016cited by this paper
• Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome.

  2016cited by this paper
• NLRP3 tyrosine phosphorylation is controlled by protein tyrosine phosphatase PTPN22.

  2016cited by this paper
• Interferons and inflammasomes: Cooperation and counterregulation in disease.

  2016cited by this paper
• Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion

  2015cited by this paper
• Lipopolysaccharide Primes the NALP3 Inflammasome by Inhibiting Its Ubiquitination and Degradation Mediated by the SCFFBXL2 E3 Ligase*

  2015cited by this paper
• Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome.

  2015cited by this paper
• FADD and Caspase-8 Mediate Priming and Activation of the Canonical and Noncanonical Nlrp3 Inflammasomes

  2014cited by this paper
• K⁺ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter.

  2013cited by this paper
• IRAK-1 bypasses priming and directly links TLRs to rapid NLRP3 inflammasome activation

  2013cited by this paper
• Cutting Edge: TLR Signaling Licenses IRAK1 for Rapid Activation of the NLRP3 Inflammasome

  2013cited by this paper
• Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation.

  2013cited by this paper
• Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity.

  2013cited by this paper
• The adaptor MAVS promotes NLRP3 mitochondrial localization and inflammasome activation.

  2013cited by this paper
• Non-transcriptional Priming and Deubiquitination Regulate NLRP3 Inflammasome Activation*

  2012cited by this paper
• NLRP3 Inflammasome Activity Is Negatively Controlled by miR-223

  2012cited by this paper
• Acute lipopolysaccharide priming boosts inflammasome activation independently of inflammasome sensor induction.

  2012cited by this paper
• Nrf2 is essential for cholesterol crystal‐induced inflammasome activation and exacerbation of atherosclerosis

  2011cited by this paper
• Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes

  2010cited by this paper
• NLRP3 inflamasomes are required for atherogenesis and activated by cholesterol crystals that form early in disease

  2010cited by this paper
• Cutting Edge: TNF-α Mediates Sensitization to ATP and Silica via the NLRP3 Inflammasome in the Absence of Microbial Stimulation1

  2009cited by this paper
• Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression1

  2009cited by this paper
• The NALP3 inflammasome is involved in the innate immune response to amyloid-β

  2008cited by this paper
• Initial description of the human NLRP3 promoter

  2008cited by this paper
• Cryopyrin activates the inflammasome in response to toxins and ATP

  2006cited by this paper
• Potentiation of Caspase-1 Activation by the P2X7 Receptor Is Dependent on TLR Signals and Requires NF-κB-Driven Protein Synthesis1

  2005cited by this paper
• Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf

  2004cited by this paper

• No citing papers are available for this paper.